Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,097 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.
Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Duncan N, et al. Among authors: shapiro a. Haemophilia. 2012 Sep;18(5):760-5. doi: 10.1111/j.1365-2516.2012.02813.x. Epub 2012 May 1. Haemophilia. 2012. PMID: 22548353
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Shapiro AD, et al. Thromb Haemost. 1998 Nov;80(5):773-8. Thromb Haemost. 1998. PMID: 9843170 Clinical Trial.
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E. Key NS, et al. Among authors: shapiro ad. Thromb Haemost. 1998 Dec;80(6):912-8. Thromb Haemost. 1998. PMID: 9869160 Clinical Trial.
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.
Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, Laurian Y, Kasper CK, Mannucci PM. Lusher JM, et al. Among authors: shapiro a. Haemophilia. 1998 Nov;4(6):790-8. doi: 10.1046/j.1365-2516.1998.00209.x. Haemophilia. 1998. PMID: 10028299 Clinical Trial.
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
Thorland EC, Drost JB, Lusher JM, Warrier I, Shapiro A, Koerper MA, Dimichele D, Westman J, Key NS, Sommer SS. Thorland EC, et al. Among authors: shapiro a. Haemophilia. 1999 Mar;5(2):101-5. Haemophilia. 1999. PMID: 10215957
Platelet function disorders.
Shapiro AD. Shapiro AD. Haemophilia. 2000 Jul;6 Suppl 1:120-7. doi: 10.1046/j.1365-2516.2000.00056.x. Haemophilia. 2000. PMID: 10982278 Review.
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Shapiro AD. Shapiro AD. Semin Thromb Hemost. 2000;26(4):413-9. doi: 10.1055/s-2000-8461. Semin Thromb Hemost. 2000. PMID: 11092217 Review.
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis.
Björkman S, Shapiro AD, Berntorp E. Björkman S, et al. Among authors: shapiro ad. Haemophilia. 2001 Mar;7(2):133-9. doi: 10.1046/j.1365-2516.2001.00465.x. Haemophilia. 2001. PMID: 11260271
Inhibitor treatment: state of the art.
Shapiro A. Shapiro A. Semin Hematol. 2001 Oct;38(4 Suppl 12):26-34. doi: 10.1016/s0037-1963(01)90144-1. Semin Hematol. 2001. PMID: 11735107 Review.
Haemophilia 2002: emerging risks of treatment.
Evatt BL, Farrugia A, Shapiro AD, Wilde JT. Evatt BL, et al. Among authors: shapiro ad. Haemophilia. 2002 May;8(3):221-9. doi: 10.1046/j.1365-2516.2002.00612.x. Haemophilia. 2002. PMID: 12010415 Review.
2,097 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback